Celldex Therapeutics
CLDX
#4691
Rank
HK$15.30 B
Marketcap
HK$230.38
Share price
6.44%
Change (1 day)
11.34%
Change (1 year)

Celldex Therapeutics (CLDX) - Total debt

Total debt on the balance sheet as of September 2025 : HK$20.39 Million

According to Celldex Therapeutics's latest financial reports the company's total debt is HK$20.39 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Celldex Therapeutics - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$29.6 M49.11%
2023-12-31HK$19.85 M-37%
2022-12-31HK$31.51 M32.84%
2021-12-31HK$23.72 M-12.1%
2020-12-31HK$26.98 M-5.25%
2019-12-31HK$28.48 M
2018-12-31N/A-100%
2017-12-31HK$51.29 M
2015-12-31HK$34.24 M70.32%
2014-12-31HK$20.1 M
2013-12-31N/A-100%
2012-12-31HK$87.88 M-25.28%
2011-12-31HK$0.11 B39.71%
2010-12-31HK$84.18 M-21.55%
2009-12-31HK$0.10 B6270.15%
2008-12-31HK$1.68 M-95.82%
2007-12-31HK$40.29 M11.59%
2006-12-31HK$36.1 M123.1%
2005-12-31HK$16.18 M1016.68%
2004-12-31HK$1.44 M
2000-12-31HK$2.14 M-51.04%
1999-12-31HK$4.37 M-64.72%
1998-12-31HK$12.39 M-0.02%
1997-12-31HK$12.39 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Seagen
SGEN
HK$0.88 B 4,229.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$0.35 B 1,646.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$5.16 B 25,199.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$424.85 B 2,082,578.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$473.58 B 2,321,456.66%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$185.72 B 910,315.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA